Nutrien (NYSE:NTR – Get Rating) had its price target decreased by stock analysts at Morgan Stanley from $100.00 to $91.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 22.79% from the company’s current price.
Other equities research analysts also recently issued research reports about the company. HSBC downgraded Nutrien from a “buy” rating to a “hold” rating in a research report on Friday, October 21st. Royal Bank of Canada cut their target price on Nutrien from $135.00 to $120.00 and set an “outperform” rating for the company in a research note on Monday, November 7th. UBS Group lowered their price target on shares of Nutrien from $110.00 to $103.00 and set a “buy” rating on the stock in a report on Wednesday. Mizuho reduced their price objective on shares of Nutrien from $124.00 to $113.00 and set a “neutral” rating for the company in a research note on Tuesday, November 1st. Finally, Raymond James lowered their target price on shares of Nutrien from $110.00 to $95.00 and set an “outperform” rating on the stock in a research note on Friday, November 4th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $101.65.
Nutrien Stock Performance
Shares of NYSE NTR traded down $0.21 during trading on Wednesday, reaching $74.11. 175,202 shares of the stock traded hands, compared to its average volume of 1,615,949. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.15 and a quick ratio of 0.70. The stock has a market capitalization of $38.14 billion, a P/E ratio of 5.29, a price-to-earnings-growth ratio of 0.74 and a beta of 0.86. Nutrien has a 52-week low of $67.41 and a 52-week high of $117.25. The company has a 50-day moving average of $76.41 and a 200-day moving average of $82.10.
Nutrien (NYSE:NTR – Get Rating) last issued its earnings results on Wednesday, November 2nd. The company reported $2.51 earnings per share for the quarter, missing analysts’ consensus estimates of $3.92 by ($1.41). Nutrien had a return on equity of 29.68% and a net margin of 20.60%. The business had revenue of $8.19 billion for the quarter, compared to the consensus estimate of $9.02 billion. Analysts forecast that Nutrien will post 13.59 EPS for the current fiscal year.
Hedge Funds Weigh In On Nutrien
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Armstrong Henry H Associates Inc. raised its position in Nutrien by 3.1% during the 4th quarter. Armstrong Henry H Associates Inc. now owns 4,483 shares of the company’s stock valued at $327,000 after purchasing an additional 135 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in shares of Nutrien by 16,144.3% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 32,651 shares of the company’s stock valued at $2,385,000 after acquiring an additional 32,450 shares in the last quarter. Optimum Investment Advisors boosted its holdings in Nutrien by 16.1% in the fourth quarter. Optimum Investment Advisors now owns 3,530 shares of the company’s stock valued at $258,000 after acquiring an additional 490 shares in the last quarter. Confluence Investment Management LLC increased its position in Nutrien by 4.5% during the 4th quarter. Confluence Investment Management LLC now owns 5,069 shares of the company’s stock valued at $370,000 after purchasing an additional 218 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in Nutrien by 36.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,513,771 shares of the company’s stock worth $126,219,000 after purchasing an additional 407,282 shares in the last quarter. 64.52% of the stock is currently owned by institutional investors.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.